Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-0994-2026

Cook Incorporated recalls Ring Transjugular Intrahepatic Access Sets

Cook IncorporatedBloomington, IN, United StatesReported Dec 31, 2025 · 6 months ago
Legal News Analyst ·

Reason for recall

Cook Medical identified that products supplied in the affected device lots may have been manufactured out of specification. Impacted products may have been cut to the incorrect length, not correctly trimmed, and not inspected properly.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Ring Transjugular Intrahepatic Access Sets, Reference Part Numbers: 1) RTPS-100; 2) RTPS-100-10.0; The Ring Transjugular Intrahepatic Access Set is intended for transjugular liver access in diagnostic and interventional procedures.

Lot / code information

Part / Item #
RTPS-100: Order Number G06541
UDI
(01)00827002065413(17)280722(10)16705779
Lot #
16705779; 2) Reference
Part / Item #
RTPS-100-10.0: Order Number G29769
UDI
(01)00827002297692(17)280624(10)16659044
Lot #
16659044

What the firm is doing

Cook Medical issued an URGENT: MEDICAL DEVICE RECALL notice to its consignees on 11/26/2025 by email and/or letter delivered via a courier. The notice explained the issue, risk to health, and requested the identification and return of the affected product. The notice must be shared with appropriate personnel, including down to the user level, within your organization or with any organization where the affected devices have been transferred. For questions or concerns, please contact Cook Medical Customer Relations at 800.457.4500 or 812.339.2235.

DistributionShow details

Worldwide distribution.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls